Dec 17, 2020
$10 Million Grant From Exact Sciences To Support Stand Up To Cancer Initiative To Improve Colorectal Cancer Screening And Prevention
Jun 04, 2020
Cancer Diagnostics Global Market Estimated to Reach $10,627.4 Million by 2026
May 26, 2020
Exact Sciences to participate in June investor conferences
May 06, 2020
Exact Sciences Announces First Quarter 2020 Results
May 05, 2020
New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates for Comparing Colorectal Cancer Screening Methods
May 04, 2020
Exact Sciences to participate in May investor conference
Apr 02, 2020
Exact Sciences Highlights The Opportunity To Seek Screening With Cologuard® Through Telehealth
Mar 19, 2020
Exact Sciences Takes Action during COVID-19 Pandemic
Mar 03, 2020
Exact Sciences Extends Leadership In Advanced Cancer Diagnostics With Acquisitions Of Paradigm And Viomics
Feb 11, 2020
Exact Sciences Announces Fourth-Quarter 2019 Results
Jan 27, 2020
Exact Sciences schedules fourth-quarter, full-year 2019 earnings call
Dec 04, 2019
Dr. David Ahlquist, co-inventor of Cologuard, named a Fellow of the National Academy of Inventors
Nov 26, 2019
Exact Sciences to participate in December investor conference
Nov 08, 2019
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company
Nov 01, 2019
Exact Sciences to participate in November investor conferences
Oct 29, 2019
Exact Sciences Presents New Stool-Based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study
Oct 29, 2019
Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
Oct 08, 2019
Exact Sciences schedules third-quarter 2019 earnings call
Sep 23, 2019
Cologuard® Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
Sep 10, 2019
Cologuard® Helps More People Get Screened In A Cost-Effective Way